ChemoCentryx(CCXI)

51.99 0.00 0.0%

今开:0.0昨收:51.99
最高:0.0 最低:0.0
涨停价:0.0跌停价:0.0
总市值:3.739105463E9

ChemoCentryx的最新讨论

Inemuri_nerd2019-11-16 08:19

$ChemoCentryx(CCXI)$ Dec期权放量了查看全文

牛唐2019-11-05 09:41

ALDX和CCXI开始起飞//@黑獭泰泰: $Aldeyra Therapeutics(ALDX)$ $ChemoCentryx(CCXI)$ $ObsEva SA(OBSV)$ 四季度看好的票查看全文

CCXI:2019年最后的彩蛋?

基岩研究院2019-10-25 11:38

2019年10月10日,UCB SA宣布对Ra Pharmaceuticals(RARX)进行收购;2019年10月16日,Alexion Pharmaceuticals (ALXN$Alexion制药(ALXN)$) 宣布现金收购Achillion Pharmaceuticals, Inc. (ACHN$爱克莱恩(ACHN)$)。美股的这两起并购事件均与补体药物相关,10月成了投资补体药物的黄金月。补体药物市...查看全文

牛唐2019-10-10 22:14

$ChemoCentryx(CCXI)$ 催化剂快了,等一等查看全文

粤昌小周2016-05-31 20:42

我刚刚关注了 $ChemoCentryx(CCXI)$ ,当前价 $5.20。查看全文

1 2 3 4 5 6 7 8 9 10 11

ChemoCentryx的新闻

ChemoCentryx(CCXI.US)股东批准安进(AMGN.US)37亿美元合并交易

智通财经APP获悉,ChemoCentryx(CCXI.US)股东以压倒性优势批准了安进(AMGN.US)以37亿美元收购ChemoCentryx的交易。 通过收购,安进获得了ChemoCentryx的核心产品Tavneos(avacopan),该药适用于严重的活动性抗中性粒细胞胞浆自身抗体(ANC... 网页链接

安进(AMGN)将以每股52美元的现金收购ChemoCentryx(CCXI) 总价值37亿美元

安进(AMGN)和ChemoCentryx(CCXI)宣布两家公司已达成最终协议,根据该协议,Amgen将以每股52美元的现金收购ChemoCentryx,这意味着ChemoCentryx的企业价值约为37亿美元。这笔交易已得到两家公司董事会的一致批准。该交易还需获得ChemoCentryx... 网页链接

ChemoCentryx的公告

持股变动声明

$ChemoCentryx(CCXI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-034086  Size: 18 KB 网页链接

持股变动声明

$ChemoCentryx(CCXI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-034087  Size: 5 KB 网页链接

持股变动声明

$ChemoCentryx(CCXI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-034089  Size: 22 KB 网页链接

持股变动声明

$ChemoCentryx(CCXI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-034081  Size: 41 KB 网页链接

持股变动声明

$ChemoCentryx(CCXI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-034084  Size: 23 KB 网页链接

持股变动声明

$ChemoCentryx(CCXI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-034075  Size: 48 KB 网页链接

持股变动声明

$ChemoCentryx(CCXI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-034076  Size: 20 KB 网页链接

持股变动声明

$ChemoCentryx(CCXI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-034077  Size: 20 KB 网页链接

持股变动声明

$ChemoCentryx(CCXI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-034068  Size: 16 KB 网页链接

持股变动声明

$ChemoCentryx(CCXI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-034069  Size: 6 KB 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76